NR Chews for a Senior Dog Who's Lost Interest in Play: What the Evidence Actually Supports

The first thing I ask an owner who tells me their senior dog “just doesn’t want to play anymore” is: what does that actually look like? Not the summary — the specifics. Does the dog still trot to the door for a walk but ignore the tennis ball? Does she get up slower after napping, or does she avoid getting up at all? The answer usually points me toward one of two very different problems, and it matters enormously before anyone reaches for a supplement.

One of the dogs I worked with this spring was a nine-year-old spayed Labrador mix, about 62 pounds, named Biscuit. Her owner said she’d “gotten lazy” over the past four months — she used to meet the mail carrier at the fence every day and now watches from the porch. On exam, Biscuit’s gait was smooth, her joints had a normal range of motion, and she wasn’t guarding anywhere. What had changed was more diffuse: she slept later, took longer to warm up in the morning, and her enthusiasm at the start of a walk faded within the first block instead of lasting the whole loop. That pattern — global slowing without a focal pain sign — is the profile where I start thinking about cellular energy support alongside the rest of a senior workup, not instead of one.

Two very different reasons a dog stops playing

Play requires three things working at once: joints that don’t hurt when they move, muscle that has enough energy to move them, and a brain state motivated enough to bother. When any one of those three falters, play is usually the first thing an older dog drops, because unlike eating or going outside, it’s optional.

If the dog is reluctant specifically around jumping, stairs, or getting up after rest, I’m thinking osteoarthritis first — Dog Hind Leg Weakness: A Neurologist’s Checklist for Telling Joint Pain From Nerve Damage walks through how we sort a joint problem from a nerve one, and it’s worth ruling out before anything else. If the slowdown is more global — less initiation, slower rousing, a flatter affect across the whole day rather than around specific movements — that’s closer to the pattern where cellular energy metabolism and mitochondrial support enter the conversation, which is where nicotinamide riboside (NR) chews live.

What NR is actually doing at the cellular level

Nicotinamide riboside is a precursor the body converts into NAD+, a coenzyme every cell needs for energy production and a long list of repair pathways. NAD+ availability declines with age across species, and restoring the precursor supply is the mechanism these chews are built around, not a promise about behavior. In dog-supplement formulations I’ve reviewed, NR typically appears around 120 mg per two-chew serving as part of a broader antioxidant blend — a dose worth checking against whatever product a client is holding, since formulations vary. A recent peer-reviewed review on NR summarized the vitamin B3 derivative’s role in NAD+ metabolism and healthy-aging research, and it’s a useful primer if you want the mechanism without the marketing — see the National Center for Biotechnology Information: Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity review.

The dog-specific evidence base is still thin, and I say that as someone who wants it to be stronger. A 2024 randomized controlled trial published in Scientific Reports found improved owner-assessed cognitive function in senior dogs given a senolytic-and-NAD+-precursor combination — a meaningfully different formulation than a straight NR chew, but the closest thing we have to a controlled canine trial in this space, and it points toward NAD+ pathway support being biologically plausible for aging dogs rather than purely theoretical.

The antioxidants riding alongside NR

Most NR chews don’t arrive alone — quercetin and resveratrol show up in the same formulations often enough that I treat them as a package when I’m evaluating a label. Quercetin is a flavonoid studied for antioxidant, immune, and cellular-support properties, and it’s a reasonable structure/function ingredient when the dose is disclosed. Resveratrol carries a similar antioxidant profile and is marketed for cellular health and vitality. Neither ingredient has canine clinical trial data behind it in this context; the supporting research is largely preclinical. A recent in-vitro study, for instance, found that “QF and unformulated Q, as well as NAC and ascorbic acid, at the concentrations used, did not affect the feeding behavior of the worms” — a nematode-model finding, useful for mechanism but not a stand-in for a dog trial (see the study in Pharmaceuticals). Separately, embryonic work on a resveratrol-related compound found that early exposure “accelerated pupation and adult emergence but shortened adult lifespan” in an insect model — a reminder that dose and life stage change the picture even for a well-studied antioxidant, and that preclinical findings don’t map cleanly onto an adult dog’s physiology (see the phytomedicine study).

Braiding it into a whole-patient plan, not a single chew

This is where I part ways with a “pick a supplement” mindset. In my practice, an NR-and-antioxidant chew is one thread in a plan, not the plan. For a dog like Biscuit, I’d pair a structure/function chew with acupuncture points selected to support qi and blood circulation, gentle Tui-na bodywork over the shoulders and hips to loosen a stiffening gait before it becomes guarding, and a food-therapy adjustment toward warming, blood-building proteins if her pattern reads as qi or blood deficiency rather than heat or stagnation. None of those four modalities does the whole job alone, and none of them is optional if the goal is actually restoring play, not just documenting a supplement on the chart. I’ve watched owners buy a chew, see no change in six weeks, and give up on the whole idea of supporting their dog’s aging — when the missed piece was that the chew was never going to fix a hip that also needed bodywork and an exam.

The Best Longevity Supplement for Senior Dogs: Our Vet Panel’s 2026 Verdict covers how our panel scores products across this category if you want the scoring rubric, and The Best NAD+ Supplement for Dogs: Our Vet Panel’s Scored Verdict goes deeper on NAD+-specific formulations if NR chews turn out not to be the right fit for your dog’s pattern.

Reading the label like a panelist would

A few things I check before I trust an NR chew on a client’s counter:

• Disclosed dose per serving, not a proprietary blend hiding the milligrams of NR, quercetin, or resveratrol.
• Third-party testing or NASC membership. The National Animal Supplement Council audits member companies and requires ongoing compliance with quality standards — it’s a floor for manufacturing trustworthiness, not a guarantee the product will work for your dog.
• Species-appropriate dosing, since NR research this deep is still mostly human and rodent data extrapolated to dogs.
• A plan for muscle, not just cells, if sarcopenia is part of the picture — Dog Muscle Supplement: What the Evidence Actually Supports is worth a read alongside this one.

What I tell owners at the recheck

Here’s the honest version.

If a senior dog’s slowdown is joint-driven, an NR chew alone won’t move the needle much, and I’ll say so plainly rather than let a supplement substitute for a pain workup. If the pattern reads as a broader energy and motivation decline without focal pain — closer to Biscuit’s presentation — I think NR, alongside quercetin and resveratrol at disclosed doses, is a defensible structure/function addition to a plan that also includes acupuncture, bodywork, and food therapy tailored to the dog’s pattern. I don’t promise it will bring the old spark back. I do think it’s a reasonable, evidence-bounded piece of a plan that treats the whole dog rather than chasing one ingredient.

I saw a twelve-year-old terrier mix, about 24 pounds, six weeks after we started this combined approach — acupuncture every two weeks, a warming food-therapy shift, and an NR-quercetin-resveratrol chew twice daily. Her owner hadn’t asked me to fix anything specific about play; she just wanted her dog “to seem like herself again,” which is a request I hear constantly and take seriously precisely because it’s so hard to quantify. What had changed by that recheck was subtle and specific: she was initiating the walk again instead of following, and she’d started carrying her favorite squeaky toy from room to room, something she hadn’t done since spring. I don’t present that as evidence the chew worked — it’s one dog, one plan, and I can’t separate which thread did what. But it’s the kind of change that tells me the whole-patient approach was pointed in the right direction.

The bottom line: a senior dog who’s lost interest in play deserves a pain and cognition workup before a chew, and if NR fits her pattern, it belongs inside a braided plan — not standing in for one.